SELECTION AND CHARACTERIZATION OF CEFEPIME-RESISTANT GRAM-NEGATIVE BACTERIA

被引:17
|
作者
PIDDOCK, LJV
GRIGGS, DJ
机构
[1] Antimicrobial Agents Research Group, Department of Medical Microbiology, The Medical School, University of Birmingham
关键词
D O I
10.1093/jac/28.5.669
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The NCTC type strains and four clinical isolates of Enterobacter cloacae, Citrobacter freundii, Serratia marcescens, Morganella morganii, Providencia stuartii and Pseudomonas aeruginosa were exposed, in agar, to cefepime at 3, 5, and 10 × MIC and a breakpoint concentration of 16 mg/L. Mutants were selected at a frequency of ̃ 10-2 that had decreased susceptibility to cefepime and cefpirome, and species-dependent resistance to other β-lactams. Any putative mutant with a greater than four-fold increase in the MIC was examined to determine its β-lactamase expression and outer membrane protein (Omp) profile. Mutant strains of P. stuartii and M. morganii lacked an Omp of molecular mass similar to that of OmpF, and were cross-resistant to nalidixic acid. Mutant strains of E. cloacae had derepressed class I β-lactamase production and lacked an Omp corresponding to OmpF, suggesting that in this species both parameters are necessary for decreased susceptibility. Derepressed β-lactamases purified from mutant strains of E. cloacae, C. freundii and P. stuartii was able to hydrolyse cefepime, but not as quickly as TEM-10. © 1991, by The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:669 / 676
页数:8
相关论文
共 50 条
  • [1] Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies
    Chong, Yong
    Yakushiji, Hiroko
    Ito, Yoshikiyo
    Kamimura, Tomohiko
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E171 - E175
  • [2] Cefepime MIC Breakpoint Resettlement in Gram-Negative Bacteria Reply
    Paterson, David L.
    Potoski, Brian A.
    Peleg, Anton Y.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) : 337 - 338
  • [3] INVITRO ACTIVITIES OF CEFEPIME ALONE AND WITH AMIKACIN AGAINST AMINOGLYCOSIDE-RESISTANT GRAM-NEGATIVE BACTERIA
    FUNGTOMC, J
    HUCZKO, E
    KOLEK, B
    THATER, C
    KESSLER, RE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) : 2652 - 2654
  • [4] Screening for antibiotic resistant Gram-negative bacteria
    Iredell, Jonathan R.
    Sintchenko, Vitali
    LANCET INFECTIOUS DISEASES, 2006, 6 (06): : 316 - 317
  • [5] Cefepime-Resistant Pseudomonas aeruginosa
    Akhabue, Ehimare
    Synnestvedt, Marie
    Weiner, Mark G.
    Bilker, Warren B.
    Lautenbach, Ebbing
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1037 - 1043
  • [6] Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu
    Nachimuthu, Ramesh
    Subramani, Ramkumar
    Maray, Suresh
    Gothandam, K. M.
    Sivamangala, Karthikeyan
    Manohar, Prasanth
    Bozdogan, Bulent
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (05) : 371 - 374
  • [7] CHARACTERIZATION AND IDENTIFICATION OF GRAM-NEGATIVE, NONFERMENTATIVE BACTERIA
    OBERHOFER, TR
    ROWEN, JW
    CUNNINGHAM, GF
    JOURNAL OF CLINICAL MICROBIOLOGY, 1977, 5 (02) : 208 - 220
  • [8] In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
    Livermore, David M.
    Mushtaq, Shazad
    Warner, Marina
    Vickers, Anna
    Woodford, Neil
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (05) : 1373 - 1385
  • [9] Antibiotics for multidrug-resistant gram-negative bacteria
    Kang, Cheol-In
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (08): : 490 - 497
  • [10] A. ANTIMICROBIALS FOR INFECTIONS BY RESISTANT GRAM-NEGATIVE BACTERIA
    不详
    ARCHIVES OF HELLENIC MEDICINE, 2019, 36 : 12 - 40